Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia

Several studies have demonstrated clinical benefits of sustained cholinesterase inhibition with rivastigmine in Alzheimer’s disease (AD) and Parkinson’s disease dementia (PDD). Unlike donepezil and galantamine that selectively inhibit acetylcholinesterase (AChE; EC 3.1.1.7), rivastigmine is a unique...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Interv Aging
Main Authors: Kandiah, Nagaendran, Pai, Ming-Chyi, Senanarong, Vorapun, Looi, Irene, Ampil, Encarnita, Park, Kyung Won, Karanam, Ananda Krishna, Christopher, Stephen
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5402908/
https://ncbi.nlm.nih.gov/pubmed/28458525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S129145
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados